Only very recently the role of the specific RHOAG17V mutation in T cell and AITL tumor development was investigated using knock-in mice for this mutation, a mouse model discussed below54,58 (see the “Inactivation of Tet2 combined with overexpression of RhoA G17V” section). The gene discussed is RHOA; the disease is angioimmunoblastic T-cell lymphoma.